We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Preservative Stabilizes Residual White Cells in Leuko-Reduced Samples

By LabMedica International staff writers
Posted on 20 May 2009
A preservative specifically stabilizes residual white blood cells (rWBCs) in leuko-reduced red blood cell samples.

Compatible with commercially available kits, Leuko Preserve is intended for detection and enumeration of rWBCs by flow cytometric analysis. More...
Flow cytometric enumeration of rWBCs in leuko-reduced blood components must be implemented within 48 hours. Occasionally, problems occur making this difficult.

Streck's (Omaha, NE, USA) Leuko Preserve stabilizes rWBCs for up to seven days following leuko-reduction, extending the timeframe for enumeration. This reduces concerns of sample backlogs, instrument problems, and shipping delays.

Additional Streck cell stabilization products include Streck Cell Preservative for the preservation of bone marrow and tissue samples; Cyto-Chex BCT (Blood Collection Tube) for the preservation of whole blood samples for immunophenotyping by flow cytometry; and Cell-Free DNA BCT, a new blood collection tube for the preservation of cell-free plasma DNA. Cell-Free DNA BCT is for research use only.

Streck has also increased the stability of its three-part Para Check whole blood hematology control. Manufactured specifically for the Sysmex KX-21, pocH-100i, and the SweLab AC920EO, the three-part control now offers closed-vial stability of 132 days. The extended closed-vial stability will allow customers to maintain a quarterly ordering schedule, decreasing shipping costs and increasing the ILQC (interlaboratory quality control) peer groups for each instrument on the assay. Para Check is available in a 2.5-ml or 3.5-ml vial with a pierceable cap to accommodate both open- and closed-mode systems.

STATS, a free interlaboratory quality control program, is offered to all Para Check customers. STATS produces relevant peer group comparison reports and graphs with a quick turnaround time. Data can be submitted by mail, fax or e-mail. The reports include customer data, peer group averages, and computer-generated Levey-Jennings graphs.

Streck is an independent developer and manufacturer of controls for the clinical laboratory.

Related Links:

Streck



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.